Dupuytren’s Disease is a progressive fibroproliferative condition of the palmar fascia, leading to digital contractures and functional impairment. Focused shock wave therapy has emerged as a non-invasive approach for managing this condition. This review aims to summarize the current evidence on the use of focal shock wave therapy in Dupuytren’s Disease, particularly regarding treatment parameters, pain reduction, quality of life and functional impact, joint range of motion and adverse effects. Available studies suggest that focused shock wave therapy in Dupuytren’s Disease appears to be a promising and non-invasive alternative, particularly for pain management and hand functionality improvement, with minimal adverse effects. However, the lack of standardized treatment protocols limits robust conclusions. Future research should include long-term follow-up and standardization of treatment parameters to better define the role of focal shock wave therapy in the management of Dupuytren’s Disease.
Santos et al. (2024) studied this question.